Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
Introduction: Donor-specific antibodies (DSAs) are considered an important risk factor for graft injury and failure. However, there is limited information on long-term outcomes for kidney transplant recipients with positive DSAs in the absence of rejection on biopsy. Methods: We evaluated all patien...
Main Authors: | Sandesh Parajuli, Emily Joachim, Sayee Alagusundaramoorthy, Fahad Aziz, Justin Blazel, Neetika Garg, Brenda Muth, Maha Mohamed, Robert R. Redfield, Didier A. Mandelbrot, Weixiong Zhong, Arjang Djamali |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919301585 |
Similar Items
-
How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy
by: Fahad Aziz, MD, et al.
Published: (2022-04-01) -
Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
by: Emily Joachim, MD,, et al.
Published: (2021-01-01) -
Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy
by: Sarah E. Panzer, et al.
Published: (2019-04-01) -
BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients
by: Sandesh Parajuli, et al.
Published: (2024-01-01) -
Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
by: Fahad Aziz, MD, et al.
Published: (2022-09-01)